Advanced Enzyme Technologies Reports 20% Revenue Growth in Q1 FY26 3 days ago
Advanced Enzyme Tech (AETL) reported strong Q1 FY26 results with consolidated revenue up 20% to ₹1,859.00 million. Net profit increased 16% to ₹404.00 million. Human nutrition segment grew 21%, contributing 66% to total revenue. Animal nutrition saw 51% growth. Domestic sales increased 32%, while international sales grew 9%. EBITDA margin stood at 30.00% and PAT margin at 22.00%.
JC Biotech, Subsidiary of Advanced Enzyme Tech, Approves Solar Power Investment Partnership with Raywatt Solar 10 days ago
Advanced Enzyme Technologies Expands into Nutrition and Wellness with New Subsidiary Jul 04, 2025
Advanced Enzyme Tech Reports Mixed Q4 Results with Revenue Growth and Profit Dip May 13, 2025
Advanced Enzyme Technologies Gears Up for Analyst and Investor Meeting Mar 13, 2025